Kodiak Sciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.About KOD
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.
KOD Key Statistics
Stock Snapshot
Kodiak Sciences(KOD) stock is priced at $38.66, giving the company a market capitalization of 2.33B. It carries a P/E multiple of -8.17.
During the trading session on 2026-03-31, Kodiak Sciences(KOD) shares reached a daily high of $39.55 and a low of $33.51. At a current price of $38.66, the stock is +15.4% higher than the low and still -2.3% under the high.
Trading activity shows a volume of 2.54M, compared to an average daily volume of 2.86M.
Over the past 52 weeks, Kodiak Sciences(KOD) stock has traded between a high of $45.60 and a low of $1.92.
Over the past 52 weeks, Kodiak Sciences(KOD) stock has traded between a high of $45.60 and a low of $1.92.
KOD News
Kodiak Sciences recently reported positive topline results from its GLOW2 Phase 3 superiority study of Zenkuda in diabetic retinopathy, where the drug significa...
Kodiak Sciences ( (KOD) ) just unveiled an update. On March 26, 2026, Kodiak Sciences reported positive topline results from GLOW2, its second Phase 3 trial in...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.